COOPERATIVE AGREEMENT WITH THE PAN AMERICAN HEALTH ORGANIZATION (PAHO) Protecting the Advances in Polio, Rubella and Measles Elimination Strengthening Immunization Programs in the Americas | Apply Online

Opportunity Summary:

This CDC funding opportunity (Funding Opportunity Number CDC-PA-IP09-901) is a discretionary cooperative agreement intended to support the Pan American Health Organization (PAHO) in protecting and sustaining the Americas region's major public health gains in the elimination of polio, rubella, and measles. The overarching aim is to prevent the re-establishment of transmission and to reinforce the systems that make elimination durable over time, especially by ensuring strong surveillance, laboratory capacity, and immunization program performance across countries in the region.

The award is structured as a cooperative agreement, meaning CDC expects to have substantial involvement in the work alongside the recipient rather than simply providing a pass-through grant. The program is focused on a mix of core disease elimination priorities (polio, measles, rubella) and broader vaccine-preventable disease (VPD) preparedness, recognizing that the same surveillance and immunization infrastructure used to keep these three diseases eliminated is also essential for detecting and controlling other VPD threats and for introducing new vaccines responsibly.

A central component of the work is strengthening surveillance in the Americas for polio, measles, rubella, and other vaccine-preventable diseases. In practical terms, this points to activities such as maintaining sensitive case detection systems, improving the timeliness and completeness of reporting, ensuring rapid investigation of suspected cases, and supporting the analytic capacity needed to identify immunity gaps or areas at elevated risk for outbreaks. Because elimination depends on finding and responding to every suspected case quickly, surveillance quality is treated as a cornerstone rather than a supporting detail.

Another major element is support for global laboratory networks for polio, measles, rubella, and other diseases that are prevented by newer vaccines. This reflects the reality that laboratory confirmation and viral/strain characterization are fundamental to verifying elimination, tracking importations, distinguishing wild-type virus from vaccine-related detections where relevant, and documenting chains of transmission. By investing in lab networks, the cooperative agreement reinforces the technical backbone required for credible verification, rapid outbreak response, and consistent regional standards.

The opportunity also emphasizes planning and implementation of supplemental immunization activities (SIAs), often referred to as supplemental immunization campaigns. These campaigns are typically used to rapidly raise population immunity, close immunity gaps, and protect cohorts that might have missed routine doses due to access barriers, program disruptions, migration, or other factors. The announcement's wording suggests an expectation of operational support and coordination, including campaign planning, monitoring of coverage, and quality improvement to ensure that campaigns reach the children and communities at highest risk.

In addition, the agreement targets strengthening routine immunization delivery systems, which is the long-term mechanism for sustaining elimination. Routine systems encompass the everyday program fundamentals: reliable vaccine supply and logistics, cold chain and handling, trained workforce, data systems that allow managers to act on coverage gaps, supervision and performance management, and community engagement to maintain demand and trust. Strong routine immunization reduces reliance on repeated campaigns and makes elimination resilient even when health systems face competing priorities.

The scope further includes the introduction of new vaccines and related capacities in developing countries. This signals that PAHO's work under the agreement is expected to help countries adopt newer vaccine products or schedules while also building the programmatic capacities that support those introductions, such as training, communications, improved data management, and laboratory or surveillance adjustments. The intent is to ensure that scaling up new vaccine prevention efforts complements, rather than distracts from, the critical mission of maintaining polio, measles, and rubella elimination.

From a funding standpoint, CDC anticipated making one award, with approximately $4.6 million available in fiscal year 2009 for that single recipient. The total estimated funding amount listed for the overall opportunity is $23 million, which typically implies a multi-year project horizon with funding dependent on appropriations and satisfactory progress. No cost sharing or matching requirement is indicated, reducing barriers related to non-federal contribution requirements.

Eligibility is limited to the PAHO Secretariat, which makes this a targeted partnership mechanism rather than an open competition among multiple types of applicants. The activity category is health, and the CFDA number provided is 93.185 (Immunization Research, Demonstration, Public Information and Education, Training and Clinical Skills Improvement Projects), placing it within CDC's immunization-related assistance portfolio.

Key dates in the listing show the opportunity was posted January 13, 2009, with an original closing date of February 12, 2009, later extended to February 19, 2009, with applications due by 5:00 pm Eastern Time on the submission date. The estimated funding date was prior to July 1, 2009, indicating an intent to move quickly so that program activities could proceed without interruption. For applicants needing access support, the contact listed is CDC's Procurement and Grants Office TIMS (telephone 770-488-2700), and the full announcement was made available through the CDC funding opportunity listings page referenced in the notice.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Drug Free Communities Support Program

Previous opportunity: CDC Grants for Public Health Research Dissertation (R36)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC PA IP09 901

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC PA IP09 901) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC PA IP09 901", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.